Less Ads, More Data, More Tools Register for FREE

Director's Dealings

6 Jun 2006 07:01

Cyprotex PLC06 June 2006 Press release 6 June 2006 Cyprotex PLC Director's Dealings Cyprotex PLC (AIM: CRX), the provider of pharmacokinetic technology andinformation, today announces that Mr Robert Morrisson Atwater, a director of theCompany, bought on Friday 2 June 2006 105,000 ordinary shares of 0.1p each inthe capital of the Company at a price of 7.25p per share. As a consequence of this purchase, Mr Atwater's interest in the share capital ofthe Company has increased to 940,000 ordinary shares representing 0.68% of theissued share capital. - Ends - For further information:Cyprotex PLCRobert Morrisson Atwater Tel: 016 2550 5100ir@cyprotex.com www.cyprotex.comCode Securities LimitedRichard Potts Tel: 020 7776 1200RVP@nomuracode.com www.codesecurities.com Media enquiries:AbchurchHeather Salmond / Georgina Bonham Tel: 020 7398 7700 heather.salmond@abchurch-group.com www.abchurch-group.com This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS